{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:20:41Z","timestamp":1783171241195,"version":"3.54.6"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.radonc.2026.111602","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:42:26Z","timestamp":1779345746000},"page":"111602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Response to \u201cBeyond binary response: toward quantitative imaging biomarkers after SBRT in prostate cancer\u201d"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-8369","authenticated-orcid":false,"given":"Sungmin","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Zelefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111602_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2026.111601","article-title":"Beyond binary response: toward quantitative imaging biomarkers after SBRT in prostate cancer","author":"Onal","year":"2026","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111602_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2026.111478","article-title":"Multiparametric MRI assessment of 6-month Post-treatment response following real-time adaptive stereotactic body radiotherapy for prostate cancer: correlation with post-treatment PSA kinetics","volume":"219","author":"Woo","year":"2026","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111602_b0015","article-title":"Imaging biomarkers in prostate stereotactic body radiotherapy: a review and clinical trial protocol","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111602_b0020","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","article-title":"Prostate magnetic resonance imaging for local recurrence reporting (PI-RR): international consensus -based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy","volume":"4","author":"Panebianco","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.radonc.2026.111602_b0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1148\/radiol.212252","article-title":"Diagnostic accuracy and observer agreement of the MRI prostate imaging for recurrence reporting assessment score","volume":"304","author":"Pecoraro","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2026.111602_b0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2214\/AJR.19.21836","article-title":"Prognostic value of pretreatment MRI in patients with prostate cancer treated with radiation therapy: a systematic review and meta-analysis","volume":"214","author":"Woo","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.radonc.2026.111602_b0035","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233055","article-title":"The QIBA profile for diffusion-weighted MRI: apparent diffusion coefficient as a quantitative imaging biomarker","volume":"313","author":"Boss","year":"2024","journal-title":"Radiology"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600441X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600441X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:46:11Z","timestamp":1783169171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402600441X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":7,"alternative-id":["S016781402600441X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111602","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to \u201cBeyond binary response: toward quantitative imaging biomarkers after SBRT in prostate cancer\u201d","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111601","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111602"}}